Short answer
European Wax Center, Inc. (EWCZ) filed an 8-K current report with the SEC on May 8, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 1.02 (Termination of a Material Definitive Agreement), Item 2.01 (Completion of Acquisition or Disposition of Assets), Item 2.03 (Creation of a Direct Financial Obligation), Item 3.01 (Notice of Delisting), Item 3.03 (Material Modification to Rights of Security Holders), Item 5.01 (Changes in Control of Registrant), Item 5.03 (Amendments to Articles of Incorporation or Bylaws), Item 8.01 (Other Events). $460M Series 2026-1 Class A-2 senior secured notes issued at 6.40% fixed interest.
- This filing includes Item 3.01, an item that often signal trouble.
European Wax Center, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- $460M Series 2026-1 Class A-2 senior secured notes issued at 6.40% fixed interest
- Up to $40M Class A-1 variable funding notes expand liquidity capacity
- Debt proceeds, equity financing and cash funded merger consideration and transaction expenses
- Notes secured by first-priority liens on substantially all securitization-entity assets
- Financing completed alongside EWCZ’s merger, making the company a wholly owned subsidiary of Parent
Item 1.02 · Termination of a Material Definitive Agreement
- $388.1M prepayment terminated 5.50% Series 2022-1 Class A-2 notes
- Repayment included $385M principal and approximately $3.1M accrued interest
- No make-whole premium or early termination penalty, limiting refinancing costs
- Prepayment funded with net proceeds from Series 2026-1 Class A-2 note issuance
Item 2.01 · Completion of Acquisition or Disposition of Assets
- Text appears truncated and does not identify an acquisition, disposition, transaction value, or closing date
- Heading references Item 2.03 financial obligations rather than Item 2.01 asset acquisition or disposition
- Investor impact cannot be assessed without the omitted filing details
Item 2.03 · Creation of a Direct Financial Obligation
- Provided text references delisting or listing-standard compliance, not creation of a direct financial obligation
- Incomplete excerpt prevents identifying the exchange, deficiency, remediation deadline, or shareholder impact
Item 3.01 · Notice of Delisting
- EWCZ intends to delist Class A Common Stock from Nasdaq and suspend trading before May 8, 2026
- Nasdaq Form 25 filing would remove the shares from exchange listing and deregister them under Exchange Act Section 12(b)
- Company plans Form 15 to deregister securities and suspend SEC reporting obligations under Sections 13 and 15(d)
- Delisting reduces public-market liquidity and company disclosure requirements, increasing shareholder information risk
Item 5.01 · Changes in Control of Registrant
- Merger completion replaced EWCZ’s entire pre-transaction board
- Merger-sub directors assumed control of the surviving corporation
- Merger-sub officers became the surviving company’s executive leadership
- Governance and strategic direction now controlled by the merger sponsor group
Item 5.03 · Amendments to Articles of Incorporation or Bylaws
- Second Amended and Restated Certificate of Incorporation adopted by European Wax Center, Inc.
- Third Amended and Restated Bylaws adopted, potentially affecting governance and shareholder rights
- Full amendment terms available in Exhibits 3.1 and 3.2 for investor review
Item 8.01 · Other Events
- European Wax Center and Parent completed the previously announced mergers on May 8, 2026
- Closing marks consummation of the transaction, potentially changing ownership and shareholder interests
- Exhibit 99.1 contains the joint press release with transaction details and closing implications
Other items in this filing:
- Item 3.03: Material Modification to Rights of Security Holders
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other European Wax Center, Inc. 8-K filings
Get the next EWCZ 8-K as it lands
Follow EWCZ for push alerts, or ask the research agent what this filing means.